Harvard spin-off CELLVIE raises $5.5M of additional funding to accelerate the development of Therapeutic Mitochondria Transplantation as a new treatment modality

/PRNewswire/ -- cellvie Inc., a leader in Therapeutic Mitochondria Transplantation (TMT), an approach developed at Harvard, closes a $5.5 Million financing to...

Related Keywords

Zurich ,Züsz ,Switzerland ,Houston ,Texas ,United States ,James Mccully ,Alexander Schueller ,Sakae Asanuma ,Frank Schueler ,Kizoo Technology Capital ,Kizoo Technology Capital Gmb ,Technology Capital ,Taiho Ventures ,Series Seed ,Kizoo Technology Capital Gmbh ,Therapeutic Mitochondria Transplantation ,Seriesa Ready ,Managing Director ,Cellvie ,